1-3 of 3
Thomas L Olson, PhD
Close
Sort by
Journal Articles

Recurrent Mutations of the C-C Motif Chemokine Ligand 22 ( CCL22 ) Define a Distinct Subgroup of Chronic Lymphoproliferative Disorder of NK Cells (CLPD-NK)

Constance Baer, PhD, Shunsuke Kimura, Ilaria Iacobucci, David J Feith, BS, PhD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Thomas L. Olson, PhD, Aakrosh Ratan, PhD, Martha-Lena Müller, PhD, Mitra Rana, Chunxu Qu, PhD, Ravi Kalathur, Claudia Haferlach, MD, Wolfgang Kern, MD, Thomas P. Loughran, Jr., MD, Charles G Mullighan, MBBS, MD, Torsten Haferlach, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-140695
Published: 2020
Journal Articles

Analysis of Genomic Landscape of Large Granular Lymphocyte Leukemia Reveals Etiologic Insights

HeeJin Cheon, BSc, Jeffrey C Xing, BS, David S Chung, BS, Mariella F Toro, BA, Cait E Hamele, BS, Thomas L. Olson, PhD, David J Feith, PhD, Aakrosh Ratan, PhD, Thomas P. Loughran, Jr., MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-137269
Published: 2020
Journal Articles

Blockade of IL-2 and IL-15 Gamma Chain Receptor Signaling Decreases Leukemic Cell Viability in T-Cell Large Granular Lymphocyte Leukemia and Adult T-Cell Leukemia

Tracy Tiffany Wang, BS, Jun Yang, MD, Yong Zhang, PhD, Meili Zhang, PhD, Kevin C Conlon, MD, Yutaka Tagaya, B.M., PhD, Thomas L Olson, PhD, David J Feith, PhD, Nazli Azimi, Pharm.D., PhD, Thomas A. Waldmann, MD, Thomas P Loughran, Jr., MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3585.
https://doi.org/10.1182/blood.V130.Suppl_1.3585.3585
Published: 2017